Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

The summary for the Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional): The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities.

Federal Grant Title:	Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-23-131
Type of Funding:	Grant
CFDA Numbers:	93.279, 93.313, 93.855, 93.865
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 7th, 2026
Original Application Deadline:	May 7th, 2026
Posted Date:	March 1st, 2023
Creation Date:	March 1st, 2023
Archive Date:	June 12th, 2026
Total Program Funding:
Maximum Federal Grant Award:	$225,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	March 1st, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-23-131.html
Grant Announcement Contact: NIH Grants Information
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial O...; • Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical...; • Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction wi...; • Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction wi...; • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the...; • Biological Testing Facility (X01 Clinical Trial Not Allowed); • Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional); • BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in th...; • BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording an...